Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Turnaround Potential

1260.1000 0.30 (0.02%)

NSE Aug 29, 2025 15:31 PM

Volume: 2.4M

Dr. Reddy's Laboratories Ltd.

06 Nov 2024

1260.10

0.02%

Dr Reddy's Labs (HOLD): Healthy Q2; margins post gRevlimid LOE to remain wary

Hold: Dr. Reddy's Laboratories Ltd.

BOB Capital Markets Ltd.

Revenue/EBITDA earnings above our and street estimates. APAT ~46% above estimates. Estimates adjusted for JV and impairment cost

Dr. Reddy's Laboratories Ltd. is trading above its 200 day SMA of 1237.7